Antidepressants Get FDA Warning
 |
|
|
|
|
March 23, 2004 |
|||
| HEALTH | ||
|
|
|
|
|
Antidepressants Get FDA Warning
Include Adults as Well as Children
By ANNA WILDE MATHEWS and SCOTT HENSLEY
Staff Reporters of THE WALL STREET JOURNAL
March 23, 2004; Page D1
The Food and Drug Administration sharply stepped up warnings about possible risks to patients taking antidepressant drugs, asking doctors, families and caregivers to watch closely for signs of increasing depression or suicidal thinking.
The FDA asked the makers of 10 major antidepressant drugs, including versions of Prozac, Wellbutrin, Paxil, Effexor and Zoloft, to place more detailed, explicit warnings on the labels for their medicines. The FDA didn't order the manufacturers to change their labels, but urged them to do so voluntarily. The new cautions would ask doctors to monitor patients for a variety of symptoms from insomnia and irritability to hostility and panic attacks that might possibly signal greater risks.
The announcement comes more than a month after an FDA advisory committee urged the agency to provide clearer warnings about possible risk of suicidal tendencies in children and adolescents taking antidepressants. Still, yesterday's development went well beyond the earlier recommendations, and included adults as well.
The most immediate result may be that doctors, particularly those who don't focus on pediatric psychiatry, become more cautious in how they prescribe antidepressants for kids and teenagers. They could start prescribing smaller doses and being slower to step up the amounts of medicine.
Doctors may also put greater emphasis on other treatment methods, particularly individual psychotherapy and perhaps family counseling, for young people suffering from depression. "People might wait until they've been in talking therapy a little bit, before trying drugs," said Richard Malone, a child psychiatrist at Drexel University College of Medicine, who was a member of the FDA advisory committee.
|
|
|||
|
|
||||
The FDA cautioned yesterday that it has not established that the drugs actually contribute to suicidal thoughts or actions, and that it will continue to gather and study data.
It's not clear if all drug companies will adhere to the FDA's new recommendation. A number of manufacturers make drugs on the FDA's list, many of which have generic alternatives. Among them: GlaxoSmithKline PLC, which markets Wellbutrin and Paxil; Pfizer Inc., which sells Zoloft; and makers of Prozac, originally developed by Eli Lilly & Co. and now available generically. Cathryn Clary, a Pfizer vice president for psychiatry and neurology, said the company does "support the FDA's recommendation."
GlaxoSmithKline spokeswoman Mary Anne Rhyne said the company is studying the language of the FDA advisory and hasn't decided whether it will change the labels on its drugs as requested. The instructions for Paxil and Wellbutrin already include precautions that a possible suicide attempt is an inherent risk in cases of major depression.
In addition to making doctors more cautious about prescribing antidepressants for kids and teenagers, the FDA move could lead doctors to gravitate more toward Prozac and its generic versions for young patients. That drug has been approved by the FDA specifically for treating major depression in children and adolescents. (Zoloft and Luvox, meanwhile -- as well as Prozac -- have been approved for obsessive-compulsive disorder in children.)
The FDA also warned parents that they need to play a role in monitoring antidepressant drugs' effects on their children. It can be particularly difficult to understand the effects of psychiatric treatments in children because they may be less able or less inclined to articulate their feelings, doctors said.
At the same time, the FDA and psychiatrists said patients shouldn't stop taking the drugs without consulting their physicians, and parents shouldn't avoid psychiatric help for children who seem troubled. Patients with untreated psychiatric disorders, such as major depression, carry an increased risk of suicide. "I worry that patients, family members or physicians might turn away from antidepressants that might be lifesaving" after hearing this warning, says Eric Hollander, a professor of psychiatry at Mount Sinai School of Medicine, New York.
It's not the first time that the FDA has spoken out on the potential risks of antidepressants. In October, the agency warned doctors to watch for suicidal thinking and suicide attempts among adolescents and children taking a number of antidepressants. That followed similar concerns raised by regulators in Britain.
The FDA advisory committee that examined the issue last month said the data were fragmented and sometimes unclear. The committee saw a "pressing need" for more study. It asked the FDA to warn doctors and the public about the possible risks. Committee members said they were particularly worried about doctors who aren't completely familiar with antidepressants prescribing them to children.
Write to Anna Wilde Mathews at anna.mathews@wsj.com1 and Scott Hensley at scott.hensley@wsj.com2
|
|
URL for this article: |
|
|
Hyperlinks in this Article: |
|
|
|||
|
Copyright © April 25, 2008 2:38 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active. REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic. Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog. You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY. Copyright © April 25, 2008 2:38 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.
|